By |

Profile

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Contact Information

Website: www.regenxbio.com
Email: natalie@argotpartners.com
Main Phone: +1 240 552-8181
Address: 9600 Blackwell Road
Address 2: Suite 210
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NGS
CEO: Kenneth T. Mills
Employees: 192
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Contact Information

Website: www.regenxbio.com
Email: natalie@argotpartners.com
Main Phone: +1 240 552-8181
Address: 9600 Blackwell Road
Address 2: Suite 210
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NGS
CEO: Kenneth T. Mills
Employees: 192
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 45.64 $ 3.16 (7.44%)
Last Price 45.64 Change $ 3.16 Change % 7.44 Tick N/A
Bid 47.00 Bid Size 200.00 Ask 48.50 Ask Size 100.00
Open 42.80 High 46.59 Low 42.25 Prev Close 42.48
Last Trade Volume 1.9 mi 52 Wk Hi 85.10 52 Wk Low 38.56
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,636,825.00 EPS (TTM) -1.09 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 97
Number of Buys 9 34
Number of Sells 21 63
Net Activity -32500 133842
Last 10 Buys Shares
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Last 10 Sell Shares
Donald J. Hayden 1,000
Donald J. Hayden 1,000
Kenneth T. Mills 1,000
Kenneth T. Mills 1,000
Kenneth T. Mills 1,000
Vittal Vasista 1,000
Vittal Vasista 1,000
Vittal Vasista 1,000
Donald J. Hayden 1,000
Donald J. Hayden 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 90 90 90 90
Low Target Price Estimate 35 35 35 35
Mean Target Price Estimate 50.17 50.17 50.17 53.17
Standard Deviation 20.19 20.19 20.19 20.78
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.79 1.79 1.79 1.79